Nemaura Medical Inc. (NMRD): Price and Financial Metrics


Nemaura Medical Inc. (NMRD): $2.61

-0.24 (-8.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NMRD Stock Price Chart Interactive Chart >

Price chart for NMRD

NMRD Price/Volume Stats

Current price $2.61 52-week high $11.10
Prev. close $2.85 52-week low $2.15
Day low $2.61 Volume 2,200
Day high $2.74 Avg. volume 12,701
50-day MA $3.03 Dividend yield N/A
200-day MA $4.42 Market Cap 62.91M

Nemaura Medical Inc. (NMRD) Company Bio


Nemaura Medical Inc. designs and develops proprietary drug delivery platforms. The Company produces therapeutic delivery systems including patches and injectors. Nemaura Medical offers its products to the pharmaceutical and healthcare industries.


NMRD Latest News Stream


Event/Time News Detail
Loading, please wait...

NMRD Latest Social Stream


Loading social stream, please wait...

View Full NMRD Social Stream

Latest NMRD News From Around the Web

Below are the latest news stories about Nemaura Medical Inc that investors may wish to consider to help them evaluate NMRD as an investment opportunity.

Nemaura Medical Launches Metabolic Health Program for Employers and Insurers

Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the launch for employers and insurers of Miboko, a new metabolic health program using a non-invas

Yahoo | January 13, 2022

Nemaura Medical Appoints Dr. Arash Ghadar as Chief Operating Officer

Loughborough, England, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the appointment of Dr. Arash (Ash) Ghadar as Chief Operating Officer. “Ash will play an important role at Nemaura as we begin to scale up our manufacturing and distribution operations. He brings ove

Yahoo | January 10, 2022

Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the H.C. Wainwright Bioconnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. The presentation will be available on-demand beginni

Yahoo | January 7, 2022

Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee

Sales in UK expected to be followed by launches across major EU territories in 2022 Loughborough, England, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces that it has completed its initial shipment of sugarBEAT® continuous glucose monitor (CGM) devices to its UK licens

Yahoo | December 7, 2021

EF Hutton Initiates a Buy Rating on Nemaura Medical (NMRD)

Nemaura Medical (NMRD – Research Report) received a Buy rating and a $7.50 price target from EF Hutton analyst EF Hutton yesterday. The company's shares closed last Thursday at $4.45, close to its 52-week low of $3.45. Nemaura Medical has an analyst consensus of Moderate Buy, with a price target consensus of $7.50. See today’s best-performing stocks on TipRanks >> The company has a one-year high of $17.40 and a one-year low of $3.45. Currently, Nemaura Medical has an average volume of 33.29K. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions.

Austin Angelo on TipRanks | December 3, 2021

Read More 'NMRD' Stories Here

NMRD Price Returns

1-mo N/A
3-mo -40.27%
6-mo -42.76%
1-year -75.58%
3-year -73.90%
5-year -95.21%
YTD -42.76%
2021 20.95%
2020 7.71%
2019 -61.11%
2018 -82.35%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5715 seconds.